BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27058893)

  • 1. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
    Wu CL; Ho JY; Chou SC; Yu DS
    Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
    Xue M; Pang H; Li X; Li H; Pan J; Chen W
    Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
    Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
    Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
    Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
    Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
    Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X
    Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.
    Yao K; He L; Gan Y; Zeng Q; Dai Y; Tan J
    Diagn Pathol; 2015 Aug; 10():146. PubMed ID: 26290438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-325-3p Overexpression Inhibits Proliferation and Metastasis of Bladder Cancer Cells by Regulating MT3.
    Sun S; Liu F; Xian S; Cai D
    Med Sci Monit; 2020 Jun; 26():e920331. PubMed ID: 32512576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway.
    Mao XW; Xiao JQ; Li ZY; Zheng YC; Zhang N
    Exp Mol Med; 2018 Jan; 50(1):e429. PubMed ID: 29350680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
    Wang J; Wang X; Liu F; Fu Y
    Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1.
    Asakura T; Yamaguchi N; Ohkawa K; Yoshida K
    Int J Oncol; 2015 May; 46(5):2251-60. PubMed ID: 25738863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells.
    Wang J; Yang X; Ruan B; Dai B; Gao Y; Duan J; Qu S; Tao K; Dou K; Li H
    Tumour Biol; 2015 Apr; 36(4):2447-56. PubMed ID: 25412960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
    Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
    Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
    Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
    Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.
    Zhang S; Zhang C; Liu W; Zheng W; Zhang Y; Wang S; Huang D; Liu X; Bai Z
    Int J Oncol; 2015 Oct; 47(4):1351-60. PubMed ID: 26252200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.